As of 06 Nov 2026 04:30 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2023/093 (03 Oct 2023): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Progesterone (Lutigest®) 100mg vaginal tabletsaffected product · inferred from phrasing | Out of stock, as stated | late December 2023precision: late in the month · window end 31 Dec 2023, derived from “late December 2023” | notice of 03 Oct 2023 |
| Progesterone (Crinone®) 8% progesterone vaginal gelaffected product · inferred from phrasing | Out of stock, as stated | late December 2023precision: late in the month · window end 31 Dec 2023, derived from “late December 2023” | notice of 03 Oct 2023 |
| Alternative progesterone productsclass-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 03 Oct 2023 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register — 1 earlier protocol on this record has expired: SSP056 (to 29 Sep 2023). Matching is by name until identifier coding lands.
Named in the source as remaining available
The latest recorded notice names no alternative as remaining available.
Identifiers — Progesterone
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Sep 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 2 times on record since 2023. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 03 Oct 2023 | Medicine Supply Notification: Progesterone (Lutigest® ) 100mg vaginal tablets and Progesterone (Crinone® ) 8% progesterone vaginal gel | Supply notification | Tier 2 | MSN/2023/093 |
| 19 May 2023 | Medicine Supply Notification: Micronised Progesterone (Utrogestan ® ) 100mg capsules | Supply notification | Tier 2 | MSN/2023/052 |
Also recorded under
Bracketed names seen in this medicine's notice titles: lutigest, utrogestan. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2023)32 Progesterone (Lutigest® ) 100mg vaginal tablets · issued 06 Oct 2023 · valid until late December 2023, as stated · matched by name PDF ↗
- MSAN(2023)10 Micronised Progesterone (Utrogestan®) 100mg capsules · issued 09 Jun 2023 · valid until end of 2023, as stated · matched by name PDF ↗